SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Kelman J) "

Sökning: WFRF:(Kelman J)

  • Resultat 1-10 av 12
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Burmester, GR, et al. (författare)
  • Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
  • 2016
  • Ingår i: Annals of the rheumatic diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 75:6, s. 1081-1091
  • Tidskriftsartikel (refereegranskat)abstract
    • The efficacy of tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, has not previously been evaluated in a population consisting exclusively of patients with early rheumatoid arthritis (RA).MethodsIn a double-blind randomised controlled trial (FUNCTION), 1162 methotrexate (MTX)-naive patients with early progressive RA were randomly assigned (1:1:1:1) to one of four treatment groups: 4 mg/kg TCZ+MTX, 8 mg/kg TCZ+MTX, 8 mg/kg TCZ+placebo and placebo+MTX (comparator group). The primary outcome was remission according to Disease Activity Score using 28 joints (DAS28–erythrocyte sedimentation rate (ESR) <2.6) at week 24. Radiographic and physical function outcomes were also evaluated. We report results through week 52.ResultsThe intent-to-treat population included 1157 patients. Significantly more patients receiving 8 mg/kg TCZ+MTX and 8 mg/kg TCZ+placebo than receiving placebo+MTX achieved DAS28-ESR remission at week 24 (45% and 39% vs 15%; p<0.0001). The 8 mg/kg TCZ+MTX group also achieved significantly greater improvement in radiographic disease progression and physical function at week 52 than did patients treated with placebo+MTX (mean change from baseline in van der Heijde–modified total Sharp score, 0.08 vs 1.14 (p=0.0001); mean reduction in Health Assessment Disability Index, −0.81 vs −0.64 (p=0.0024)). In addition, the 8 mg/kg TCZ+placebo and 4 mg/kg TCZ+MTX groups demonstrated clinical efficacy that was at least as effective as MTX for these key secondary endpoints. Serious adverse events were similar among treatment groups. Adverse events resulting in premature withdrawal occurred in 20% of patients in the 8 mg/kg TCZ+MTX group.ConclusionsTCZ is effective in combination with MTX and as monotherapy for the treatment of patients with early RA.Trial registration numberClinicalTrials.gov, number NCT01007435
  •  
8.
  •  
9.
  •  
10.
  • Ettema, Thijs J. G., et al. (författare)
  • Rolf Bernander (1956-2014) : pioneer of the archaeal cell cycle Obituary
  • 2014
  • Ingår i: Molecular Microbiology. - : John Wiley & Sons. - 0950-382X .- 1365-2958. ; 92:5, s. 903-909
  • Tidskriftsartikel (populärvet., debatt m.m.)abstract
    • On 19 January 2014 Rolf (Roffe') Bernander passed away unexpectedly. Rolf was a dedicated scientist; his research aimed at unravelling the cell biology of the archaeal domain of life, especially cell cycle-related questions, but he also made important contributions in other areas of microbiology. Rolf had a professor position in the Molecular Evolution programme at Uppsala University, Sweden for about 8 years, and in January 2013 he became chair professor at the Department of Molecular Biosciences, The Wenner-Gren Institute at Stockholm University in Sweden. Rolf was an exceptional colleague and will be deeply missed by his family and friends, and the colleagues and co-workers that he leaves behind in the scientific community. He will be remembered for his endless enthusiasm for science, his analytical mind, and his quirky sense of humour.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 12
Typ av publikation
tidskriftsartikel (8)
konferensbidrag (3)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (8)
övrigt vetenskapligt/konstnärligt (3)
populärvet., debatt m.m. (1)
Författare/redaktör
Rubbert-Roth, A (5)
Kelman, A (5)
Kay, J. (4)
Mitchell, N (4)
van Vollenhoven, RF (4)
Dimonaco, S (4)
visa fler...
Rigby, W (3)
Kelman, Ilan (3)
Liu, Yang (2)
Liu, Zhao (2)
Andersson, Anders F. (2)
Costello, Anthony (2)
Springmann, Marco (2)
Moradi-Lakeh, Maziar (2)
Robinson, Elizabeth ... (2)
Burmester, GR (2)
Ettema, Thijs J. G. (2)
Hjort, Karin (2)
Kniveton, Dominic (2)
Sewe, Maquins Odhiam ... (2)
Nilsson, Maria, 1957 ... (2)
Gong, Peng (2)
Belesova, Kristine (2)
Otto, Matthias (2)
Wagner, Fabian (2)
Bowen, Kathryn (2)
Graham, Hilary (2)
Sofiev, Mikhail (2)
Ebi, Kristie L. (2)
Burmester, G (2)
Hamilton, Ian (2)
Kaessmann, Henrik (2)
Davies, Michael (2)
van Daalen, Kim R. (2)
Semenza, Jan C. (2)
Lowe, Rachel (2)
Winning, Matthew (2)
Hess, Jeremy J. (2)
Poplawski, Andrzej B ... (2)
Grogan, Dennis W. (2)
Kelman, Zvi (2)
Murray, Kris A (2)
Lemke, Bruno (2)
Owfi, Fereidoon (2)
Tabatabaei, Meisam (2)
Jay, Ollie (2)
Campbell-Lendrum, Di ... (2)
Shumake-Guillemot, J ... (2)
Dubrow, Robert (2)
Dasgupta, Shouro (2)
visa färre...
Lärosäte
Karolinska Institutet (7)
Umeå universitet (2)
Kungliga Tekniska Högskolan (2)
Uppsala universitet (1)
Örebro universitet (1)
Språk
Engelska (12)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (3)
Naturvetenskap (2)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy